文献速递细菌感染、耐药与抗菌药物医院感染防控

快速碳青霉烯酶失活法(rCIM)评估:一种表型筛查产碳青霉烯酶肠杆菌科细菌的检测方法

Evaluation of the rapid carbapenem inactivation method (rCIM): a phenotypic screening test for carbapenemase-producing Enterobacteriaceae.
PubMed 文献 · J Antimicrob Chemother · 2018-01-01

rCIM通过美罗培南纸片孵育待测菌后,用上清液攻击指示菌并用浊度计监测生长,在113株特征明确的肠杆菌分离株中与CIM和Carba NP比较,并在2017年7月法国国家抗菌药物耐药参考中心前瞻性分析101株碳青霉烯耐药肠杆菌分离株。rCIM在回顾性收集中正确识别84/85株产碳青霉烯酶菌和28/28株非产碳青霉烯酶菌,敏感性99%、特异性100%;在前瞻性验证中敏感性和特异性分别为97%和95%。rCIM是一种快速(小于3小时)、廉价且准确的CPE检测方法,可在资源有限环境中实施。

要点

  • rCIM正确识别84/85株产碳青霉烯酶菌和28/28株非产酶菌,敏感性99%、特异性100%。
  • 前瞻性验证中rCIM敏感性和特异性分别为97%和95%。
  • 两株高产头孢菌素酶阴沟肠杆菌假阳性,一株产IMI-17阿氏肠杆菌假阴性。

核心结论

  • rCIM是一种快速(小于3小时)、廉价且准确的CPE检测方法,可在资源有限环境中实施,是微生物实验室的有用工具。

研究设计与样本

  • rCIM由待测菌与美罗培南纸片孵育、取上清液攻击敏感指示菌并用浊度计监测指示菌生长组成。
  • 使用113株特征明确的碳青霉烯耐药肠杆菌分离株(包括85株产碳青霉烯酶菌和28株非产碳青霉烯酶菌),将rCIM与CIM和Carba NP试验比较。
  • 在2017年7月法国国家抗菌药物耐药参考中心的前瞻性分析中,对101株碳青霉烯耐药肠杆菌分离株将rCIM与Carba NP试验和PCR测序比较。

主要发现

  • rCIM正确识别84/85株产碳青霉烯酶菌和28/28株非产碳青霉烯酶菌,敏感性99%、特异性100%,略高于CIM和Carba NP试验。
  • 在前瞻性验证研究中,rCIM的敏感性和特异性分别为97%和95%。
  • 两株高产头孢菌素酶阴沟肠杆菌(Enterobacter cloacae)给出假阳性结果,一株产IMI-17阿氏肠杆菌(Enterobacter asburiae)给出假阴性结果。
  • 该分离株在含选择性抗生素的培养基上生长时,结果呈阳性。

局限性

  • 两株高产头孢菌素酶阴沟肠杆菌给出假阳性结果,一株产IMI-17阿氏肠杆菌给出假阴性结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Fast and accurate diagnostic tests to identify carbapenemase-producing Enterobacteriaceae (CPE) are mandatory for proper antimicrobial therapy and implementing infection control measures. Here, we have developed a rapid Carbapenem Inactivation Method (rCIM) for CPE detection. METHODS: The rCIM consists of the incubation of a potential carbapenemase producer with meropenem discs and use of the resulting supernatant to challenge a susceptible indicator strain. Growth of the indicator strain is monitored using a nephelometer. The performances of the rCIM were compared with the CIM and Carba NP tests using a collection of 113 well-characterized carbapenem-resistant enterobacterial isolates, including 85 carbapenemase producers and 28 non-carbapenemase producers. In addition, rCIM was compared with the Carba NP test and PCR sequencing in a prospective analysis of 101 carbapenem-resistant enterobacterial isolates addressed to the French National Reference Center for Antimicrobial Resistance in July 2017. RESULTS AND DISCUSSION: The rCIM correctly identified 84/85 carbapenemase producers and 28/28 non-carbapenemase producers, yielding a sensitivity of 99% and a specificity of 100%, slightly higher than the CIM and Carba NP test. In the prospective validation study, the rCIM showed a sensitivity and specificity of 97% and 95%, respectively. Two cephalosporinase-hyperproducing Enterobacter cloacae gave false-positive results, whereas an IMI-17-producing Enterobacter asburiae gave a false-negative result. The result was, however, positive when the isolate was grown on selective antibiotic-containing media. CONCLUSIONS: The rCIM is a rapid (less than 3 h), cheap and accurate test for the detection of CPEs, which can be implemented in low-resource settings, making it a useful tool for microbiology laboratories.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Muntean MM, Muntean AA, Gauthier L, et al. Evaluation of the rapid carbapenem inactivation method (rCIM): a phenotypic screening test for carbapenemase-producing Enterobacteriaceae. J Antimicrob Chemother. 2018. PMID: 29351668. doi:10.1093/jac/dkx519

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。